Article
Prognostic and predictive biomarkers in melanoma: an update
30 Nov 2015
Abstract excerpt
Malignant melanoma is one of the most aggressive cancers. Several new therapeutic strategies that focus on immuno- and/or targeted therapy have been developed, which have entered clinical trials or already been approved. This review provides an update on prognostic and predictive biomarkers in melanoma that may be used to improve the clinical management of patients. Prognostic markers include conventional...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
